Shannon J. Turley
Amgen Inc.
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Strong evidence · 1 supporting paper · latest 2026
Immune cells in cancer
Strong evidence · 1 supporting paper · latest 2026
Cell Adhesion Molecules Research
Solid evidence · 1 supporting paper · latest 2026
Cancer Immunotherapy and Biomarkers
Solid evidence · 1 supporting paper · latest 2026
Cancer Cells and Metastasis
Solid evidence · 3 supporting papers · latest 2026
Microtubule and mitosis dynamics
Solid evidence · 1 supporting paper · latest 2026
Fibroblast Growth Factor Research
Solid evidence · 1 supporting paper · latest 2026
TGF-β signaling in diseases
Supporting evidence · 1 supporting paper · latest 2026
Publications (5)
Functional heterogeneity of macrophages in distinct niches of hepatocellular carcinoma
2026DOIPMID 42457464
TGFb signaling instructs a conserved fibrosis-associated cell state marked by LRRC15
2026DOIPMID 42160341
Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
2026DOI
Fibroblast TGF-β3 promotes tissue-residency and survival of CD8 T cells in barrier tissues and tumors
2026DOI
Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts
2026DOIPMID 42349429
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Amgen Inc.
Source: OpenAlex · retrieved 2026-09-29